IP Verse

Suzhou Pengxu Pharmatech competitive analysis

Latest publications and patents of Suzhou Pengxu Pharmatech New

Explore the latest publications and patents granted to Suzhou Pengxu Pharmatech, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Suzhou Pengxu Pharmatech

EP3302441
Dec 13, 2023Processes To Produce BrivaracetamGranted And Under Opposition
EP3229799
Oct 17, 2018Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods ThereofRevoked
EP3071554
Oct 3, 2018Crystalline Forms Of Lesinurad And Its Sodium SaltOpposition Rejected

Latest patents of Suzhou Pengxu Pharmatech opposed by its competitors

Explore Suzhou Pengxu Pharmatech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3302441
Dec 13, 2023Processes To Produce Brivaracetam3
EP3229799
Oct 17, 2018Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof1
EP3071554
Oct 3, 2018Crystalline Forms Of Lesinurad And Its Sodium Salt1

Latest PTAB cases involving Suzhou Pengxu Pharmatech

Discover the latest PTAB cases involving Suzhou Pengxu Pharmatech, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Suzhou Pengxu Pharmatech with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SUZHOU PENGXU PHARMATECH - 5 - - Non-Active
D YOUNG29 - - - Highly Aggressive
FRY HEATH & SPENCE1 - - - Highly Aggressive
HGF73 - - - Highly Aggressive